Williams Timothy
SEC CIK 1748392 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | SVP, GC | 377.4K | — | $959.9K | 14 | 2021-08-16 | 2026-03-02 |
Most active insiders at VNDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Polymeropoulos Mihael Hristos | Pres, CEO, Dir, COB | — | $1.28M |
| 2 | Moran Kevin Patrick | SVP, CFO, Treas | — | $351.0K |
| 3 | Williams Timothy | SVP, GC | — | $350.9K |
| 4 | Birznieks Gunther | SVP, Business Development | — | $350.9K |
| 5 | Wijkstrom Joakim | SVP, CMO | — | $254.7K |
| 6 | Honore Tage | Dir | — | $240.9K |
| 7 | McGuire Daniel Patrick | SVP, GC, Sec | — | — |
| 8 | Duncan Charles Cliff | Dir | — | — |
| 9 | Mitchell Stephen Ray | Dir | — | — |
| 10 | Ward Anne Sempowski | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $8.27 | -42.4K | 377.4K | -10% | -$350.9K | |
| 2026-02-19 | 2026-02-18 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | A - Grant | $0.00 | +125.0K | 419.9K | +42% | $0 | |
| 2025-03-04 | 2025-03-01 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | F - Tax | $4.76 | -26.9K | 294.9K | -8% | -$128.2K | |
| 2025-02-20 | 2025-02-18 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | A - Grant | $0.00 | +125.0K | 321.8K | +64% | $0 | |
| M | 2024-03-06 | 2024-03-04+ | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $4.29 | -17.1K | 196.8K | -8% | -$73.3K |
| 2024-02-21 | 2024-02-16 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | A - Grant | $0.00 | +125.0K | 213.9K | +141% | $0 | |
| 2023-06-15 | 2023-06-13 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $6.56 | -14.6K | 88.9K | -14% | -$95.8K | |
| M | 2023-03-06 | 2023-03-02+ | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $6.24 | -16.7K | 111.8K | -13% | -$104.5K |
| D | 2023-02-21 | 2023-02-16 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | A - Grant | $0.00 | +32.7K | 120.3K | +37% | $0 |
| 2022-12-16 | 2022-12-15 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $7.01 | -8,000 | 87.6K | -8% | -$56.1K | |
| M | 2022-08-17 | 2022-08-15 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $10.30 | -8,300 | 95.6K | -8% | -$85.5K |
| D | 2022-03-02 | 2022-02-28 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | A - Grant | $0.00 | +32.7K | 115.9K | +39% | $0 |
| D | 2022-03-02 | 2022-03-02 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $11.09 | -12.1K | 103.9K | -10% | -$133.7K |
| 2021-08-17 | 2021-08-16 | VNDA | Vanda Pharmaceuticals Inc. | Williams Timothy | SVP, GC | S - Sale | $16.15 | -3,715 | 83.2K | -4% | -$60.0K |
Purchase Sale Sale after option exercise All abbreviations